Burak Cem Soner

552 total citations
30 papers, 433 citations indexed

About

Burak Cem Soner is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Burak Cem Soner has authored 30 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Burak Cem Soner's work include Sexual function and dysfunction studies (4 papers), Hormonal and reproductive studies (4 papers) and Bee Products Chemical Analysis (4 papers). Burak Cem Soner is often cited by papers focused on Sexual function and dysfunction studies (4 papers), Hormonal and reproductive studies (4 papers) and Bee Products Chemical Analysis (4 papers). Burak Cem Soner collaborates with scholars based in Türkiye, United States and Serbia. Burak Cem Soner's co-authors include Şule Ayla, Ayşe Saide Şahin, Gülperi Öktem, İsmail Seçkin, Gamze Tanrıverdi, Müjgan Cengiz, Eda Açıkgöz, Gülperi Öktem, Fahriye Düzağaç and Sedef Gidener and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Progress in Neuro-Psychopharmacology and Biological Psychiatry.

In The Last Decade

Burak Cem Soner

26 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Burak Cem Soner Türkiye 12 117 68 67 64 53 30 433
Ayliz Velioğlu‐Öğünç Türkiye 12 169 1.4× 87 1.3× 71 1.1× 78 1.2× 89 1.7× 16 632
Yuka Kohda Japan 14 150 1.3× 77 1.1× 42 0.6× 175 2.7× 51 1.0× 35 586
May Abu‐Taha Jordan 8 192 1.6× 79 1.2× 62 0.9× 50 0.8× 49 0.9× 12 610
Rongrong Li China 14 283 2.4× 73 1.1× 48 0.7× 34 0.5× 83 1.6× 37 728
Zihui Zheng China 14 291 2.5× 59 0.9× 38 0.6× 37 0.6× 61 1.2× 42 577
Füsun Erdenen Türkiye 16 182 1.6× 44 0.6× 39 0.6× 40 0.6× 69 1.3× 38 650
Zohara Sternberg United States 16 170 1.5× 89 1.3× 21 0.3× 173 2.7× 33 0.6× 39 713
Azize Şener Türkiye 12 120 1.0× 47 0.7× 33 0.5× 46 0.7× 27 0.5× 33 542
Mohamed El‐Shafey Egypt 16 176 1.5× 27 0.4× 37 0.6× 44 0.7× 35 0.7× 27 495
Mustafa Ark Türkiye 15 258 2.2× 45 0.7× 56 0.8× 21 0.3× 26 0.5× 45 591

Countries citing papers authored by Burak Cem Soner

Since Specialization
Citations

This map shows the geographic impact of Burak Cem Soner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burak Cem Soner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burak Cem Soner more than expected).

Fields of papers citing papers by Burak Cem Soner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burak Cem Soner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burak Cem Soner. The network helps show where Burak Cem Soner may publish in the future.

Co-authorship network of co-authors of Burak Cem Soner

This figure shows the co-authorship network connecting the top 25 collaborators of Burak Cem Soner. A scholar is included among the top collaborators of Burak Cem Soner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burak Cem Soner. Burak Cem Soner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Şahin, Ayşe Saide, et al.. (2025). Effects of safranal on antidiabetic and endothelial dysfunction in streptozotocin-induced diabetic rats. Molecular Biology Reports. 52(1). 741–741.
2.
Açıkgöz, Eda, et al.. (2021). CD133+/CD44+ prostate cancer stem cells exhibit embryo-like behavior patterns. Acta Histochemica. 123(5). 151743–151743. 14 indexed citations
3.
4.
Ayla, Şule, Ayhan Bılır, Gamze Tanrıverdi, et al.. (2018). E ects of di erent drug treatments on the proliferation of human ovarian carcinoma cell line MDAH-2774. TURKISH JOURNAL OF MEDICAL SCIENCES. 48(2). 441–448. 2 indexed citations
5.
Soner, Burak Cem, Ömer Demir, Tevfik Demir, et al.. (2017). Time-course changes of nLDL-induced erectile dysfunction. International Journal of Impotence Research. 29(3). 115–119. 5 indexed citations
6.
Soner, Burak Cem, et al.. (2016). Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson’s disease. Metabolic Brain Disease. 31(4). 849–857. 6 indexed citations
8.
Alp, Hayrullah, Burak Cem Soner, Tamer Baysal, & Ayşe Saide Şahin. (2014). Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats. The Anatolian Journal of Cardiology. 15(12). 970–975. 19 indexed citations
9.
Soner, Burak Cem, et al.. (2014). Infralimbic cortex Rho-kinase inhibition causes antidepressant-like activity in rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 57. 36–43. 15 indexed citations
10.
Soner, Burak Cem & Ayşe Saide Şahin. (2014). Cardiovascular effects of resveratrol and atorvastatin treatments in an H2O2-induced stress model. Experimental and Therapeutic Medicine. 8(5). 1660–1664. 7 indexed citations
11.
Soner, Burak Cem, et al.. (2014). Effects Of Caffeic Acid Phenethyl Ester On Isolated Human Umbilical Arteries Precontracted With Endothelin And Prostaglandin F2ALPHA. Clinical Therapeutics. 36(8). e5–e5. 1 indexed citations
12.
Soner, Burak Cem, Hüseyin Aktuğ, Eda Açıkgöz, et al.. (2014). Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol. International Journal of Molecular Medicine. 34(5). 1249–1256. 38 indexed citations
13.
Uslu, Serap, Çağrı A. Uysal, Ayhan Bılır, Burak Cem Soner, & Gülperi Öktem. (2013). Hepatic progenitor cell inhibition during embryonic period with high dose verapamil; liable joint to the cancer therapy. Bratislavské lekárske listy/Bratislava medical journal. 114(7). 369–375. 5 indexed citations
14.
Soner, Burak Cem, et al.. (2013). The role of calcium entry on the relaxation response of rho-kinase inhibitor in rabbit renal artery. Bratislavské lekárske listy/Bratislava medical journal. 114(5). 258–261. 1 indexed citations
15.
Ayla, Şule, Ayhan Bılır, Burak Cem Soner, et al.. (2013). Notch Signaling–related Therapeutic Strategies With Novel Drugs in Neuroblastoma Spheroids. Journal of Pediatric Hematology/Oncology. 36(1). 37–44. 14 indexed citations
16.
Dayanç, Murat, Yusuf Kibar, Ali Uğur Ural, et al.. (2012). The Histopathologic, Pharmacologic and Urodynamic Results of Mesenchymal Stem Cell’s Injection into the Decompensated Rabbit’s Bladder. Stem Cell Reviews and Reports. 8(4). 1245–1253. 9 indexed citations
17.
Soner, Burak Cem, et al.. (2010). Evaluation of vascular smooth muscle and corpus cavernosum on hypercholesterolemia. Is resveratrol promising on erectile dysfunction?. International Journal of Impotence Research. 22(4). 227–233. 16 indexed citations
18.
Öktem, Gülperi, Serap Uslu, Ayşegül Uysal, et al.. (2009). Kanser Kök Hücresi ve Notch Yolağında Umut Veren Ortak Embriyonik Dönem inhibisyonu. DergiPark (Istanbul University). 40(1). 23–27. 1 indexed citations
19.
Soner, Burak Cem, et al.. (2009). Contractility of Diabetic Human Corpus Cavernosum Smooth Muscle in Response to Serotonin Mediated via Rho-Kinase. Pharmacology. 84(1). 24–28. 6 indexed citations
20.
Soner, Burak Cem, et al.. (2006). Vasorelaxant effect of iloprost on isolated human internal mammary artery. Fundamental and Clinical Pharmacology. 21(1). 75–79. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026